134 related articles for article (PubMed ID: 18776537)
1. Thymidine phoshorylase as a target for antiangiogenesis treatment.
Peters GJ; Bijnsdorp IV; Fukushima M
Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells.
Bijnsdorp IV; Azijli K; Jansen EE; Wamelink MM; Jakobs C; Struys EA; Fukushima M; Kruyt FA; Peters GJ
Biochem Pharmacol; 2010 Sep; 80(6):786-92. PubMed ID: 20488166
[TBL] [Abstract][Full Text] [Related]
3. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior.
Bijnsdorp IV; de Bruin M; Laan AC; Fukushima M; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):681-91. PubMed ID: 18600526
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.
Hotchkiss KA; Ashton AW; Klein RS; Lenzi ML; Zhu GH; Schwartz EL
Cancer Res; 2003 Jan; 63(2):527-33. PubMed ID: 12543812
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
Yu EJ; Lee Y; Rha SY; Kim TS; Chung HC; Oh BK; Yang WI; Noh SH; Jeung HC
Mol Cancer Res; 2008 Oct; 6(10):1554-66. PubMed ID: 18922971
[TBL] [Abstract][Full Text] [Related]
6. Increased migration by stimulation of thymidine phosphorylase in endothelial cells of different origin.
Bijnsdorp IV; Vrijland K; Vroling L; Fukushima M; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):482-7. PubMed ID: 20544542
[TBL] [Abstract][Full Text] [Related]
7. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.
El-Naggar M; Ebbing E; Bijnsdorp I; van den Berg J; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):413-21. PubMed ID: 24940699
[TBL] [Abstract][Full Text] [Related]
9. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.
Bijnsdorp IV; Capriotti F; Kruyt FA; Losekoot N; Fukushima M; Griffioen AW; Thijssen VL; Peters GJ
Br J Cancer; 2011 Mar; 104(7):1185-92. PubMed ID: 21386840
[TBL] [Abstract][Full Text] [Related]
12. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
[TBL] [Abstract][Full Text] [Related]
14. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.
Fox SB; Moghaddam A; Westwood M; Turley H; Bicknell R; Gatter KC; Harris AL
J Pathol; 1995 Jun; 176(2):183-90. PubMed ID: 7636628
[TBL] [Abstract][Full Text] [Related]
16. Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells
Bijnsdorp IV; Peters GJ
Cancer Drug Resist; 2021; 4(3):719-727. PubMed ID: 35582304
[No Abstract] [Full Text] [Related]
17. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor.
Han HS; Hwang TS
Oncol Rep; 2007 Jan; 17(1):61-5. PubMed ID: 17143479
[TBL] [Abstract][Full Text] [Related]
18. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
Jones A; Fujiyama C; Turner K; Cranston D; Williams K; Stratford I; Bicknell R; Harris AL
J Urol; 2002 Mar; 167(3):1482-6. PubMed ID: 11832774
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
de Bruin M; van Capel T; Smid K; van der Born K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1485-90. PubMed ID: 15571282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
